Live from the NIH registry
Studies recruiting near Columbia right now
Top 25 of 195 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Columbia, South Carolina (7.9 mi)
· Sponsor: Medtronic
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Insomnia Disorder
Phase 3
Interventional 420 participants sought
Vanda Investigational Site — Columbia, South Carolina (7.9 mi)
· Sponsor: Vanda Pharmaceuticals
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma
Phase 3
Interventional 562 participants sought
Lexington Health — West Columbia, South Carolina (10.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Prisma Health Richland Hospital — Columbia, South Carolina (7.9 mi)
· Sponsor: National Cancer Institute (NCI)
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
Coronary Artery Disease (CAD)
N/A
Observational 5,000 participants sought
Prisma Health Richland Hospital — Columbia, South Carolina (7.9 mi)
· Sponsor: HeartFlow, Inc.
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Sleep Wake Disorders, Sleep Disorders, Circadian Rhythm
Phase 3
Interventional 70 participants sought
Vanda Investigational Site — Columbia, South Carolina (7.9 mi)
· Sponsor: Vanda Pharmaceuticals
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Prisma Health Richland Hospital — Columbia, South Carolina (7.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Columbia Nephrology — Columbia, South Carolina (7.9 mi)
· Sponsor: CSL Behring
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Prisma Health Richland Hospital — Columbia, South Carolina (7.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
Macular Edema Secondary to Inflammation
Phase 3
Interventional 600 participants sought
Palmetto Retina Center (West Columbia) — West Columbia, South Carolina (10.2 mi)
· Sponsor: Kodiak Sciences Inc
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.
Hidradenitis Suppurativa
Phase 2
Interventional 240 participants sought
Columbia Dermatology & Aesthetics — Columbia, South Carolina (7.9 mi)
· Sponsor: Pfizer
The Goal is to Examine the Impact of Doula-delivered, Nurse-coordinated Postpartum Care Among Individuals With Preterm Births <34 Weeks' Gestation Requiring NICU Admission.
Doula Support, Postpartum
N/A
Interventional 350 participants sought
Prisma Health Richland — Columbia, South Carolina (7.9 mi)
· Sponsor: University of South Carolina
Beneficial or Fostering Future Struggles (B.F.F.s)? Characterizing the Role of Friends in the Development of 13- to 17-Year-Old Adolescents
Child Maltreatment, Interpersonal Relations
N/A
Interventional 120 participants sought
University of South Carolina — Columbia, South Carolina (7.9 mi)
· Sponsor: University of South Carolina
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Chronic Spontaneous Urticaria
Phase 2
Interventional 200 participants sought
Columbia Dermatology & Aesthetics — Columbia, South Carolina (7.9 mi)
· Sponsor: Pfizer
Mindful Walking Neural Correlates of Executive Function in SC Older Adults at Risk of Dementias
Older Adults With Elevated Dementia Risk
Phase 2
Interventional 54 participants sought
University of South Carolina — Columbia, South Carolina (7.9 mi)
· Sponsor: University of South Carolina
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
Growth Hormone Deficiency
N/A
Observational 900 participants sought
Ascendis Investigational Site — Columbia, South Carolina (7.9 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Columbia, South Carolina (7.9 mi)
· Sponsor: Alnylam Pharmaceuticals
A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy
Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy
Phase 3
Interventional 88 participants sought
Takeda Site 17 — Columbia, South Carolina (7.9 mi)
· Sponsor: Takeda
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Narcolepsy Type 2
Phase 3
Interventional 176 participants sought
Alkermes Investigational Site — Columbia, South Carolina (7.9 mi)
· Sponsor: Alkermes, Inc.
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
Amblyopia
Phase 3
Interventional 544 participants sought
Prisma Health — Columbia, South Carolina (7.9 mi)
· Sponsor: Jaeb Center for Health Research
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Growth Hormone Deficiency
N/A
Observational 500 participants sought
Ascendis Investigational Site — Columbia, South Carolina (7.9 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
West Columbia — West Columbia, South Carolina (10.2 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
Core Semantic Systems TMS
Lexical Access in Neurotypicals
N/A
Interventional 36 participants sought
Prisma Health Richland — Columbia, South Carolina (7.9 mi)
· Sponsor: University of South Carolina
Efficacy of Center-based Childcare to Mitigate Unhealthy Weight Gain in Preschoolers From Low-income Households During the Summer
Obesity & Overweight
N/A
Interventional 300 participants sought
University of South Carolina — Columbia, South Carolina (7.9 mi)
· Sponsor: University of South Carolina
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Prisma Health Richland Hospital — Columbia, South Carolina (7.9 mi)
· Sponsor: National Cancer Institute (NCI)